Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study.
Mohamed Said IsmailLoay KassemAhmed Al-Husseiny AliFatma Elzahraa AhmedMohamed ShalabySally MagdyPublished in: Journal of the Egyptian National Cancer Institute (2023)
Screening patients with newly diagnosed non-squamous NSCLC for driver mutations is essential for major prognostic and therapeutic implications. Early administration of TKIs in mutated patients significantly improves disease outcomes.